Clinical research of Zhenqifuzheng granule combined with Tegafur gimeracil oteracil potassim capsule in treating advanced carcinoma of gastric cardia in aged patients
10.3760/cma.j.issn.0254-9026.2014.12.014
- VernacularTitle:贞芪扶正颗粒联合替吉奥胶囊治疗老年人晚期贲门癌的临床研究
- Author:
Ke LI
;
Xu ZHANG
- Publication Type:Journal Article
- Keywords:
Stomach neoplasms;
Pyrimidines;
Strengthening body resistance
- From:
Chinese Journal of Geriatrics
2014;33(12):1314-1316
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the clinical effect of Zhenqifuzheng granule combined with Tegafur gimeracil oteracil potassium capsule in treating advanced carcinoma of gastric cardia in aged patients.Methods 52 cases of aged patients with advanced carcinoma of gastric cardia were randomly divided into the observation group and the control group.The observation group was treated with zhenqi fuzheng granule combined with tegafur gimeracil oteracil potassium capsule,and the control group was given Tegafur gimeracil oteracil potassium capsule only.The curative effect,adverse reaction and cellular immune function were evaluated after two treatment cycles.Results There was no statistically significant difference in the objective efficacy rate between observation (46.2％) and control group (50.0％) (P＞0.05).The rate of adverse reaction was higher in the control group than in observation group (P＜0.05).The rate of gastrointestinal adverse reactions in the control group was 50.0％,but 15.4％ in observation group.The rate of bone marrow suppression was 26.9％ in control group,but 11.5％ in observation group.The cellular immune function was better in observation group than in the control group (P＜0.05).Conclusions Zhenqifuzheng granule can improve immune function and reduce toxic side effects when combined with Tegafur gimeracil oteracil potassim capsule in treating advanced carcinoma of gastric cardia in aged patients.
